The role of endocannabinoids in the regulation of gastric emptying

alterations in mice fed a high-fat diet

V Di Marzo, R Capasso, I Matias, G Aviello, S Petrosino, F Borrelli, B Romano, P Orlando, F Capasso, A A Izzo

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Endocannabinoids (via cannabinoid CB(1) receptor activation) are physiological regulators of intestinal motility and food intake. However, their role in the regulation of gastric emptying is largely unexplored. The purpose of the present study was to investigate the involvement of the endocannabinoid system in the regulation of gastric emptying in mice fed either a standard diet (STD) or a high-fat diet (HFD) for 14 weeks.

EXPERIMENTAL APPROACH: Gastric emptying was evaluated by measuring the amount of phenol red recovered in the stomach after oral challenge; CB(1) expression was analysed by quantitative reverse transcription-PCR; endocannabinoid (anandamide and 2-arachidonoyl glycerol) levels were measured by liquid chromatography-mass spectrometry.

KEY RESULTS: Gastric emptying was reduced by anandamide, an effect counteracted by the CB(1) receptor antagonist rimonabant, but not by the CB(2) receptor antagonist SR144528 or by the transient receptor potential vanilloid type 1 (TRPV1) antagonist 5'-iodoresiniferatoxin. The fatty acid amide hydrolase (FAAH) inhibitor N-arachidonoyl-5-hydroxytryptamine (but not the anandamide uptake inhibitor OMDM-2) reduced gastric emptying in a way partly reduced by rimonabant. Compared to STD mice, HFD mice exhibited significantly higher body weight and fasting glucose levels, delayed gastric emptying and lower anandamide and CB(1) mRNA levels. N-arachidonoylserotonin (but not rimonabant) affected gastric emptying more efficaciously in HFD than STD mice.

CONCLUSIONS AND IMPLICATIONS: Gastric emptying is physiologically regulated by the endocannabinoid system, which is downregulated following a HFD leading to overweight.

Original languageEnglish
Pages (from-to)1272-1280
Number of pages9
JournalBritish Journal of Pharmacology
Volume153
Issue number6
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Endocannabinoids
Gastric Emptying
High Fat Diet
rimonabant
Diet
Phenolsulfonphthalein
Gastrointestinal Motility
Cannabinoids
Liquid Chromatography
Reverse Transcription
Fasting
Mass Spectrometry
Serotonin
Stomach
Down-Regulation
Eating
Body Weight
Glucose
Polymerase Chain Reaction
Messenger RNA

Keywords

  • Animals
  • Arachidonic Acids
  • Blood Glucose
  • Body Weight
  • Cannabinoid Receptor Modulators
  • Chromatography, Liquid
  • Dietary Fats
  • Down-Regulation
  • Endocannabinoids
  • Gastric Emptying
  • Male
  • Mass Spectrometry
  • Mice
  • Mice, Inbred ICR
  • Phenolsulfonphthalein
  • Polyunsaturated Alkamides
  • RNA, Messenger
  • Receptor, Cannabinoid, CB1
  • Reverse Transcriptase Polymerase Chain Reaction
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Di Marzo, V., Capasso, R., Matias, I., Aviello, G., Petrosino, S., Borrelli, F., ... Izzo, A. A. (2008). The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. British Journal of Pharmacology, 153(6), 1272-1280. https://doi.org/10.1038/sj.bjp.0707682

The role of endocannabinoids in the regulation of gastric emptying : alterations in mice fed a high-fat diet. / Di Marzo, V; Capasso, R; Matias, I; Aviello, G; Petrosino, S; Borrelli, F; Romano, B; Orlando, P; Capasso, F; Izzo, A A.

In: British Journal of Pharmacology, Vol. 153, No. 6, 03.2008, p. 1272-1280.

Research output: Contribution to journalArticle

Di Marzo, V, Capasso, R, Matias, I, Aviello, G, Petrosino, S, Borrelli, F, Romano, B, Orlando, P, Capasso, F & Izzo, AA 2008, 'The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet', British Journal of Pharmacology, vol. 153, no. 6, pp. 1272-1280. https://doi.org/10.1038/sj.bjp.0707682
Di Marzo, V ; Capasso, R ; Matias, I ; Aviello, G ; Petrosino, S ; Borrelli, F ; Romano, B ; Orlando, P ; Capasso, F ; Izzo, A A. / The role of endocannabinoids in the regulation of gastric emptying : alterations in mice fed a high-fat diet. In: British Journal of Pharmacology. 2008 ; Vol. 153, No. 6. pp. 1272-1280.
@article{906ea77714024795b1a09506c7c83a40,
title = "The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet",
abstract = "BACKGROUND AND PURPOSE: Endocannabinoids (via cannabinoid CB(1) receptor activation) are physiological regulators of intestinal motility and food intake. However, their role in the regulation of gastric emptying is largely unexplored. The purpose of the present study was to investigate the involvement of the endocannabinoid system in the regulation of gastric emptying in mice fed either a standard diet (STD) or a high-fat diet (HFD) for 14 weeks.EXPERIMENTAL APPROACH: Gastric emptying was evaluated by measuring the amount of phenol red recovered in the stomach after oral challenge; CB(1) expression was analysed by quantitative reverse transcription-PCR; endocannabinoid (anandamide and 2-arachidonoyl glycerol) levels were measured by liquid chromatography-mass spectrometry.KEY RESULTS: Gastric emptying was reduced by anandamide, an effect counteracted by the CB(1) receptor antagonist rimonabant, but not by the CB(2) receptor antagonist SR144528 or by the transient receptor potential vanilloid type 1 (TRPV1) antagonist 5'-iodoresiniferatoxin. The fatty acid amide hydrolase (FAAH) inhibitor N-arachidonoyl-5-hydroxytryptamine (but not the anandamide uptake inhibitor OMDM-2) reduced gastric emptying in a way partly reduced by rimonabant. Compared to STD mice, HFD mice exhibited significantly higher body weight and fasting glucose levels, delayed gastric emptying and lower anandamide and CB(1) mRNA levels. N-arachidonoylserotonin (but not rimonabant) affected gastric emptying more efficaciously in HFD than STD mice.CONCLUSIONS AND IMPLICATIONS: Gastric emptying is physiologically regulated by the endocannabinoid system, which is downregulated following a HFD leading to overweight.",
keywords = "Animals, Arachidonic Acids, Blood Glucose, Body Weight, Cannabinoid Receptor Modulators, Chromatography, Liquid, Dietary Fats, Down-Regulation, Endocannabinoids, Gastric Emptying, Male, Mass Spectrometry, Mice, Mice, Inbred ICR, Phenolsulfonphthalein, Polyunsaturated Alkamides, RNA, Messenger, Receptor, Cannabinoid, CB1, Reverse Transcriptase Polymerase Chain Reaction, Journal Article, Research Support, Non-U.S. Gov't",
author = "{Di Marzo}, V and R Capasso and I Matias and G Aviello and S Petrosino and F Borrelli and B Romano and P Orlando and F Capasso and Izzo, {A A}",
year = "2008",
month = "3",
doi = "10.1038/sj.bjp.0707682",
language = "English",
volume = "153",
pages = "1272--1280",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The role of endocannabinoids in the regulation of gastric emptying

T2 - alterations in mice fed a high-fat diet

AU - Di Marzo, V

AU - Capasso, R

AU - Matias, I

AU - Aviello, G

AU - Petrosino, S

AU - Borrelli, F

AU - Romano, B

AU - Orlando, P

AU - Capasso, F

AU - Izzo, A A

PY - 2008/3

Y1 - 2008/3

N2 - BACKGROUND AND PURPOSE: Endocannabinoids (via cannabinoid CB(1) receptor activation) are physiological regulators of intestinal motility and food intake. However, their role in the regulation of gastric emptying is largely unexplored. The purpose of the present study was to investigate the involvement of the endocannabinoid system in the regulation of gastric emptying in mice fed either a standard diet (STD) or a high-fat diet (HFD) for 14 weeks.EXPERIMENTAL APPROACH: Gastric emptying was evaluated by measuring the amount of phenol red recovered in the stomach after oral challenge; CB(1) expression was analysed by quantitative reverse transcription-PCR; endocannabinoid (anandamide and 2-arachidonoyl glycerol) levels were measured by liquid chromatography-mass spectrometry.KEY RESULTS: Gastric emptying was reduced by anandamide, an effect counteracted by the CB(1) receptor antagonist rimonabant, but not by the CB(2) receptor antagonist SR144528 or by the transient receptor potential vanilloid type 1 (TRPV1) antagonist 5'-iodoresiniferatoxin. The fatty acid amide hydrolase (FAAH) inhibitor N-arachidonoyl-5-hydroxytryptamine (but not the anandamide uptake inhibitor OMDM-2) reduced gastric emptying in a way partly reduced by rimonabant. Compared to STD mice, HFD mice exhibited significantly higher body weight and fasting glucose levels, delayed gastric emptying and lower anandamide and CB(1) mRNA levels. N-arachidonoylserotonin (but not rimonabant) affected gastric emptying more efficaciously in HFD than STD mice.CONCLUSIONS AND IMPLICATIONS: Gastric emptying is physiologically regulated by the endocannabinoid system, which is downregulated following a HFD leading to overweight.

AB - BACKGROUND AND PURPOSE: Endocannabinoids (via cannabinoid CB(1) receptor activation) are physiological regulators of intestinal motility and food intake. However, their role in the regulation of gastric emptying is largely unexplored. The purpose of the present study was to investigate the involvement of the endocannabinoid system in the regulation of gastric emptying in mice fed either a standard diet (STD) or a high-fat diet (HFD) for 14 weeks.EXPERIMENTAL APPROACH: Gastric emptying was evaluated by measuring the amount of phenol red recovered in the stomach after oral challenge; CB(1) expression was analysed by quantitative reverse transcription-PCR; endocannabinoid (anandamide and 2-arachidonoyl glycerol) levels were measured by liquid chromatography-mass spectrometry.KEY RESULTS: Gastric emptying was reduced by anandamide, an effect counteracted by the CB(1) receptor antagonist rimonabant, but not by the CB(2) receptor antagonist SR144528 or by the transient receptor potential vanilloid type 1 (TRPV1) antagonist 5'-iodoresiniferatoxin. The fatty acid amide hydrolase (FAAH) inhibitor N-arachidonoyl-5-hydroxytryptamine (but not the anandamide uptake inhibitor OMDM-2) reduced gastric emptying in a way partly reduced by rimonabant. Compared to STD mice, HFD mice exhibited significantly higher body weight and fasting glucose levels, delayed gastric emptying and lower anandamide and CB(1) mRNA levels. N-arachidonoylserotonin (but not rimonabant) affected gastric emptying more efficaciously in HFD than STD mice.CONCLUSIONS AND IMPLICATIONS: Gastric emptying is physiologically regulated by the endocannabinoid system, which is downregulated following a HFD leading to overweight.

KW - Animals

KW - Arachidonic Acids

KW - Blood Glucose

KW - Body Weight

KW - Cannabinoid Receptor Modulators

KW - Chromatography, Liquid

KW - Dietary Fats

KW - Down-Regulation

KW - Endocannabinoids

KW - Gastric Emptying

KW - Male

KW - Mass Spectrometry

KW - Mice

KW - Mice, Inbred ICR

KW - Phenolsulfonphthalein

KW - Polyunsaturated Alkamides

KW - RNA, Messenger

KW - Receptor, Cannabinoid, CB1

KW - Reverse Transcriptase Polymerase Chain Reaction

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1038/sj.bjp.0707682

DO - 10.1038/sj.bjp.0707682

M3 - Article

VL - 153

SP - 1272

EP - 1280

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 6

ER -